RxDoctor Payments Data

Jessica Mosher, MD

MOHS-Micrographic Surgery · Wellesley Hills, MANPI 1063471050

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by AbbVie at 55.1% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in MA, where the typical reported total is $746.

$164in general payments, 2019–2025

Across 8 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$90
  • Novartis$25
  • Dermira, Inc.$20
  • Amgen$16
  • Sanofi$12

What the payments were for

  • Food & beverage$164100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie4$90
Novartis1$25
Dermira, Inc.1$20
Amgen1$16
Sanofi1$12

How this compares

$164 in reported general payments places this provider in the 25th percentile of 38 mohs-micrographic surgery providers in Massachusetts.

See all mohs-micrographic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$665,370
Medicare patients
329
Services billed
1,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate67$1,008
Gentamicin Sulfate31$995
ErythromycinErythromycin Base38$972
Mupirocin73$554
Cephalexin83$412
Minocycline Hcl16$328
Tramadol Hcl56$75
Azithromycin11$39
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$18

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Wellesley Hills

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →